Portfolio company
Edinburgh Molecular Imaging
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops fluorescent imaging agents to help clinicians detect and visualise cancer and other diseases in real time during medical procedures.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Fluolink
Fluolink develops optical guidance systems and fluorescence spectroscopy sensors for neurosurgeons to identify brain tumours and cerebral microcirculation during surgical procedures.
Celluminova
This company develops luminescent biomarkers to detect and visualise cancer stem cells for use by medical researchers, pathologists and neurosurgeons.
Marginum
This company manufactures fluorescence-based tissue monitoring devices for surgeons to identify cancerous cells in surgical suction waste during oncological procedures.
Lightpoint
This company develops miniaturised imaging and sensing tools for intra-operative cancer detection to assist surgeons during robot-assisted procedures.
SamanTree Medical
This company develops digital microscopy scanners for surgeons and pathologists to perform real-time assessment of fresh tissue samples during cancer surgery.
Briteseed
This company develops real-time deep-tissue imaging tools for surgeons to identify blood vessels, nerves and ureters during minimally invasive procedures.
Endomag
This company develops magnetic sensing systems and surgical markers for breast cancer localisation and lymphatic tracing used by surgeons and radiologists.
Clee Medical
The company develops an intraoperative imaging and navigation platform for neurosurgeons to perform minimally invasive brain surgery with real-time tissue and vasculature visualization.
